Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats (Q28138163)

https://api.crossref.org/works/10.1177%2F026988119801200410

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Pemoline-associated fulminant liver failure: testing the evidence for causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Attention deficit disorder: a review of the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Case study: adverse response to clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

A teacher rating scale for use in drug studies with children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Do High Doses of Stimulants Impair Flexible Thinking in Attention-Deficit Hyperactivity Disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

The effects of a multimodal intervention with attention-deficit hyperactivity disorder children: a 9-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Some reasons for concern about attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

The diagnosis and prevalence of hyperactivity in Chinese schoolboys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Nicotine effects on adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Aggression in boys with attention deficit-hyperactivity disorder: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Inattentive and hyperactive behaviors and driving offenses in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Comparative effects of methylphenidate on ADD girls and ADD boys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Prevalence of mental disorder in military children and adolescents: findings from a two-stage community survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Neurobehavioural mechanisms of reward and motivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Bupropion effects in attention deficit and conduct disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Methylphenidate in Hyperkinetic Children: Differences in Dose Effects on Learning and Social Behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Differential Effects of Methylphenidate on Working Memory in ADHD Children with and without Comorbid Anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Improvements in performance without nicotine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Social judgment processes in hyperactive boys: effects of methylphenidate and comparisons with normal peers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410

Therapeutic Interventions to Prevent Delinquency in Hyperactive Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988119801200410